摘要
重组人干扰素是一类具有抗病毒、抗肿瘤、免疫调节等生物活性的细胞因子。本文从专利申请的角度对重组人干扰素的宿主表达、突变体、化学修饰、融合蛋白等研究进展进行了回顾。
Recombinant human interferon（rh IFN） contains a family of cytokines that display a wide range of biological activities, such as antiviral, antitumor, and immunomodulatory etc. The progress in research on recombinant human interferon, such as host expression, mutants, chemical modification and fusion proteins, was reviewed in this paper from the standpoint of the patent applications.
出处
《中国发明与专利》
2018年第2期15-19,共5页
China Invention & Patent
关键词
重组人干扰素
表达系统
修饰
融合
recombinant human interferon
expression system
modification
fusion
